Analyst recommendations: Amazon, AstraZeneca, Glencore, Morphic, Phoenix Group...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list includes only companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

Amazon: Phillip Securities downgrades to neutral from buy. PT up 5.5% to $133.

AstraZeneca: Morgan Stanley moves from Overweight to Equal-weight with a GBp 12,000 target.

Dice Therapeutics: Stifel starts at Buy With $37 Price Target

Glencore: Credit Suisse still considers the stock as a Buy opportunity. The target price has been raised to GBp 720 from GBp 570.

Morphic: Stifel Starts Morphic at Buy With $44 Price Target.

Phoenix Group: Morgan Stanley moves from Equal-Weight to Underweight, targeting GBp 660.

Prudential: UBS advises its customers to buy the stock. The target price is reduced from GBp 1685 to GBp 1580.